
Novo Nordisk invests in new factory in Denmark
DANISH pharmaceutical giant Novo Nordisk, maker of diabetes and weightloss treatments Ozempic and Wegovy, said it was investing US$1.2 billion to build a new factory in Denmark to produce drugs against rare diseases. The 40,000-square-metre (430,000-square-feet) production facility and warehouse in Odense “marks the first time in this century that








